Cleveland Clinic Nephrology Update 2025

Cleveland Clinic Nephrology Update 2025

139.97 USD In stock Buy at Merchant

+ Include: 12 videos + 34 pdfs, size: 8 GB + Target Audience: nephrologists, rheumatologists, internists, maternal fetal medicine providers + Information: Cleveland Clinic Nephrology Update 2025. This year’s update will provide a review of the most up-to-date data and analyze it for implications in clinical practice, as well as focus on the most recent current topics that impact your practice. Cleveland Clinic Nephrology Update 2025 features experts that will address diagnosis and management strategies for patients with kidney disease. By Attending, You Will Be Able To: Describe and critically appraise recent advancements in chronic kidney disease management, including the integration of novel pharmacotherapies such as SGLT2 inhibitors, GLP-receptor agonists, and non-steroidal MRAs into treatment plans. Discuss the management of various complications in CKD and ESKD. Discuss obesity in CKD and the role of nephrology providers. Evaluate the latest evidence-based treatment strategies for IgA nephropathy and lupus nephritis, with a focus on novel therapies. Analyze the role of complement activation in various kidney diseases and explore the role of novel therapeutic interventions targeting the complement system. Highlight updated approaches to managing kidney-related complications in cancer patients, including the nephrotoxic effects of immune checkpoint inhibitors and targeted cancer therapeutics. Review the basics of dialysis vascular access and critically appraise recent advances in the field. Assess the unique challenges of managing kidney disease in pregnant patients, including hypertension, preeclampsia, and acute kidney injury, with a focus on balancing maternal and fetal health. Who Should Attend? This activity is designed for nephrologists, rheumatologists, internists, maternal fetal medicine providers, nurses, nurse practitioners, physician assistants, and other practicing health care professionals who desire an update on recent advancements in chronic kidney disease management, treatment strategies for IgA nephropathy and lupus nephritis, managing kidney-related complications in cancer patients, and the unique challenges of managing kidney disease in pregnant patients. + Topics: Agenda.pdf Session I Updates and Challenges in CKD Care (Part 1) Anticoagulation in CKD and ESKD.pdf Session I Updates and Challenges in CKD Care (Part 1) Calciphylaxis and Skin Issues in CKD.pdf Session I Updates and Challenges in CKD Care (Part 1) CKD KDIGO Guidelines Update.pdf Session I Updates and Challenges in CKD Care (Part 1).mp4 Session II Updates and Challenges in CKD Care (Part 2) Hypertension Management in CKD.pdf Session II Updates and Challenges in CKD Care (Part 2) Nutrition and CKD.pdf Session II Updates and Challenges in CKD Care (Part 2) Obesity and CKD.pdf Session II Updates and Challenges in CKD Care (Part 2).mp4 Session III Vascular Access Symposium- An Update for the Nephrologist 1.pdf Session III Vascular Access Symposium- An Update for the Nephrologist 2.pdf Session III Vascular Access Symposium- An Update for the Nephrologist 3.pdf Session III Vascular Access Symposium.mp4 Session IV Journal Club 1.pdf Session IV Journal Club 2.pdf Session IV Journal Club.mp4 Session V Updates in Glomerular Diseases (Part 1) Genetics in Primary Nephrotic Syndrome.pdf Session V Updates in Glomerular Diseases (Part 1) Kidney Success- Clinical Trials in Nephrology.pdf Session V Updates in Glomerular Diseases (Part 1) Update in Primary Nephrotic Syndrome.pdf Session V Updates in Glomerular Diseases (Part 1).mp4 Session VI Updates in Glomerular Diseases (Part 2) CAR-T for Autoimmune diseases.pdf Session VI Updates in Glomerular Diseases (Part 2) IgA Nephropathy Update.pdf Session VI Updates in Glomerular Diseases (Part 2) Lupus Nephritis Update.pdf Session VI Updates in Glomerular Diseases (Part 2).mp4 Session VII Kasperzak Lecture and Case Discussions Clinicopathologic Case Discussions.pdf Session VII Kasperzak Lecture and Case Discussions Kasperzak Lecture- Complement in Kidney Diseases 1.pdf Session VII Kasperzak Lecture and Case Discussions Kasperzak Lecture- Complement in Kidney Diseases 2.pdf Session VII Kasperzak Lecture and Case Discussions.mp4 Session VIII Vasculitis Update and Case Discussions Clinicopathologic Case Discussions.pdf Session VIII Vasculitis Update and Case Discussions Vasculitis Mimics.pdf Session VIII Vasculitis Update and Case Discussions What’s New in Vasculitis.pdf Session VIII Vasculitis Update and Case Discussions.mp4 Session IX Update in Onco-nephrology Case Discussions in Onconephrology.pdf Session IX Update in Onco-nephrology Immunotherapy and the Kidneys.pdf Session IX Update in Onco-nephrology TKI and VEGF Inhibitors.pdf Session IX Update in Onco-nephrology.mp4 Session X Monoclonal Gammopathy of Renal Significance (MGRS) A Primer into MGRS- What a Nephrologist Should Know.pdf Session X Monoclonal Gammopathy of Renal Significance (MGRS) Case Discussions in MGRS.pdf Session X Monoclonal Gammopathy of Renal Significance (MGRS).mp4 Session XI Obstetric Nephrology AKI in Pregnancy.pdf Session XI Obstetric Nephrology Case Discussions in Obstetric Nephrology.pdf Session XI Obstetric Nephrology GN in Pregnancy CKD Pregnancy Counseling.pdf Session XI Obstetric Nephrology.mp4 Session XII Updates in the World of Kidney Transplantation Medical Updates in Kidney Transplant.pdf Session XII Updates in the World of Kidney Transplantation Surgical Updates in Kidney Transplant.pdf Session XII Updates in the World of Kidney Transplantation.mp4

AI Readiness

Good foundation, but some important product data is still missing.

72%